SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-074722
Filing Date
2024-03-22
Accepted
2024-03-22 09:46:00
Documents
8

Document Format Files

Seq Description Document Type Size
1 DEFA14A d780936ddefa14a.htm DEFA14A 24653
2 GRAPHIC g7809361grab002.jpg GRAPHIC 878
3 GRAPHIC g7809361grad002.jpg GRAPHIC 1666
4 GRAPHIC g7809361grae002.jpg GRAPHIC 1462
5 GRAPHIC g7809361graf002.jpg GRAPHIC 2464
6 GRAPHIC g780936sp002.jpg GRAPHIC 2222
7 GRAPHIC g780936spa01.jpg GRAPHIC 5851
8 GRAPHIC g780936spb01.jpg GRAPHIC 7383
  Complete submission text file 0001193125-24-074722.txt   56912
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35409 | Film No.: 24773436
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)